Mr. Paul Muller
Founder and CEO

Founder and CEO of NISO Biomed Startup in biomed. The company has developed and now selling EndoFaster a device that performs gastric juice analysis in real time during gastroscopy. Previous activities: Founder and managing partner of Quantica SGR / Principia SGR .Venture Capital raised and managing 2 funds (31M€, 63M€); General Manager of Rete Ventures Technology transfer company in science of materials area.

Sectors of Personal Expertise: Life Sciences

  NISO biomed
, Italy

NISO Biomed is a start up biomedical company, operating in the field of gastroenterology and the fight against cancer of the digestive system. NISO Biomed introduces on market the device EndoFaster 21-42 - the result of 10 years of research and experimentation and validation clinics - leading real-time analysis during gastroscopic examination of the gastric juice: EndoFaster improves diagnosis, reduces the invasiveness and hospital costs. Endofaster 21-42 has all international quality certifications required by current legislation: ISO 9001, ISO 13485 and CE. It is placed on the market after a long period of clinical trial under direction, guidance and supervision of Professor Repici– Istituto ClinicoHumanitas (MI) and Professor Costamagna – Policlinico Gemelli - Roma. NISO Biomed device (EndoFaster)target market at international level. Now the device has CE mark that open all European, most Middle eastern, Asian and South American countries.


 Organisation Activities
Activity: private company (start-up/sme) with an innovative product, technology or service
Technology Sectors: life sciences